The Utility of Rapid Nucleic Acid Amplification Testing to Triage Symptomatic Patients and to Screen Asymptomatic Preprocedure Patients for SARS-CoV-2 | Zendy

Joseph A. Tworek | Zendy; Faisal Khan | Zendy; Matthew D. Sekedat | Zendy; Caleb Scheidel | Zendy; Anurag N. Malani | Zendy

Open Access

The Utility of Rapid Nucleic Acid Amplification Testing to Triage Symptomatic Patients and to Screen Asymptomatic Preprocedure Patients for SARS-CoV-2

Author(s) -

Joseph A. Tworek,

Faisal Khan,

Matthew D. Sekedat,

Caleb Scheidel,

Anurag N. Malani

Publication year - 2020

Publication title -

open forum infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.546

H-Index - 35

ISSN - 2328-8957

DOI - 10.1093/ofid/ofaa607

Subject(s) - asymptomatic , medicine , triage , nucleic acid amplification tests , covid-19 , emergency medicine , pediatrics , intensive care medicine , virology , disease , chlamydia trachomatis , outbreak , infectious disease (medical specialty)

We investigate the utility of the ID Now when compared to RT-PCR to triage patients suspected of having COVID-19 presenting to emergency rooms (ERs) and to screen asymptomatic patients presenting for pre-procedural testing. We find it useful when prevalence of COVID-19 is high in symptomatic patents and potentially useful in asymptomatic patients who are likely to be retested if symptoms emerge.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research